Anzeige
Mehr »
Login
Dienstag, 05.03.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Explodiert nach dem Goldpreis-Ausbruch jetzt auch Silber?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Edison Investment Research

ZeitAktuelle NachrichtenRatingLeser
MoCreo Medical - MicroBlate Flex progresses with first robotics use140Creo Medical has marked another milestone in advancing utility of its electrosurgical devices with the first use of its MicroBlate Flex device in a robotic-guided lung tissue ablation procedure (as...
► Artikel lesen
MoUltimovacs - Peer-reviewed publication reiterates UV1's potential133Ultimovacs' results from the Phase II NIPU trial for its universal, off-the-shelf cancer vaccine UV1 in second-line metastatic pleural mesothelioma (MPM) have been published in the European Journal...
► Artikel lesen
Moabrdn Private Equity Opportunities Trust - Returns and buyback help narrow the discount105abrdn Private Equity Opportunities Trust (APEO) achieved a 5.4% NAV total return (TR) in FY23 (to end-September 2023) despite muted private equity (PE) deal activity and foreign exchange headwinds (its...
► Artikel lesen
MoUIL - Long-term focus, avoiding short-term noise88UIL Limited (UIL) is managed by Charles Jillings and his highly experienced team at value-based specialist investor ICM. It is a unique portfolio of undervalued assets, which is illustrated by the fund's...
► Artikel lesen
MoAAC Clyde Space - Strong order backlog underpins growth prospects110In FY23, AAC was largely affected by continuing supplier delays, which compromised the anticipated delivery of subsystems and delayed projects, with subsequent key revenue deferred. Nevertheless, Q423...
► Artikel lesen
MoAGBA - US$5m placement at a premium202On 15 February AGBA announced term sheets have been executed on a US$5.1m private placement of ordinary shares plus warrants to an institutional investor and AGBA's group president and management. The...
► Artikel lesen
MoMGI - Media and Games Invest - Back on a growth track236MGI - Media and Games Invest (MGI) had a good Q423, gaining market share in an improving trading environment. Organic revenue growth of 16% in the quarter helped lift the full year figure to +5%. This...
► Artikel lesen
Mo4iG - Record FY23 results; transformation plan underway1624iG's FY23 results showed good revenue and EBITDA growth on a reported and pro forma basis. The Telco business, which includes an 11 month contribution from the Vodafone Hungary acquisition, showed...
► Artikel lesen
FrRegional REIT - Lancing the boil?137Regional REIT (RGL) has declared an unchanged Q423 DPS of 1.2p per share and is making good progress with asset sales. However, with H223 property valuations following the market lower, and a subsequent...
► Artikel lesen
FrScandic Hotels Group - Tender indeed is the North207Newly confirmed strong finances (just 0.6x net debt/adjusted EBITDA including convertible loan) and continued Nordic market resilience, allied with multiple growth initiatives, are justifiably reinforcing...
► Artikel lesen
FrDar Global - Initial FY23 results exceed revised guidance180Dar Global's FY23 results showed impressive growth driven by a range of positive factors, which bodes well for 2024 and beyond. Dar Global is in the early stages of delivering over 5,700 residences...
► Artikel lesen
FrSenSen Networks - Clear path to sustainable cash generation176In H124 SenSen delivered positive free cash flow for the first time, a key milestone. The group's Smart Cities focus and standardised business model supported steady top-line progression, as well as...
► Artikel lesen
DoNano Dimension - Share buyback underway184Nano Dimension has provided a business update that highlights a major R&D milestone, a system sale to a defence customer and the start of a $200m share buyback programme. Management is focused on optimising...
► Artikel lesen
DoGood Life Plus - Welcome to the Goodlife!76Good Life Plus (GL+) is an early-stage, entertainment-focused, subscription-based prize draw operator. Based in the UK, the business was founded in 2021. The majority of GL+'s members pay a subscription...
► Artikel lesen
DoS&U - Impairments drag FY24 PBT, moderation in FY25134In its trading update between December 2023 and January 2024, S&U announced that FY24 PBT will be 10% to 15% below consensus of c £38m. The key reason is lower collection rates in Advantage of 90% (H123:...
► Artikel lesen
DoThe Law Debenture Corporation - One plus one equals three123FY23 results for The Law Debenture Corporation (LWDB) show this well-proven, rare combination of a UK investment trust and the cash-generative professional services operating business (IPS) continuing...
► Artikel lesen
DoFreelancer - Primed for margin expansion158Freelancer's FY23 results marked a key milestone as the group moved to positive operating EBITDA. Profitability was driven by lower opex than we anticipated as gross marketplace volume (GMV) and revenue...
► Artikel lesen
DoActinogen Medical - Pressing forward with Xanamem149Having shown cognitive activity in prior trials, Actinogen began its XanaMIA Phase IIb study of lead candidate Xanamem in patients with cognitive impairment (CI) associated with mild-to-moderate Alzheimer's...
► Artikel lesen
MiOSE Immunotherapeutics - Confidence boost with AbbVie partnership362OSE Immunotherapeutics has announced a global licence and collaboration agreement with AbbVie to develop OSE-230, a novel monoclonal antibody, for the treatment of chronic and severe inflammation. The...
► Artikel lesen
27.02.Pan American Silver - FY23 results: Follow the cash flow564Pan American Silver (PAAS) has released its FY23 financial results, which are in line with our estimates at the EBITDA level, an encouraging outcome given the operationally challenging year. While the...
► Artikel lesen
27.02.CLIQ Digital - Steady progress and share buyback announced388CLIQ Digital showed robust revenue and profit growth in FY23 despite a more challenging backdrop. Revenue was below management guidance and Edison estimates, but profits were in line. Margins dipped...
► Artikel lesen
27.02.OSE Immunotherapeutics - Encouraging OSE-279 clinical update151At the 2024 ESMO Targeted Anticancer Therapies Congress, OSE Immunotherapeutics (OSE) presented encouraging interim results from the Phase I/II dose escalation and expansion study for OSE-279, its anti-PD1...
► Artikel lesen
27.02.Immix Biopharma - 2023 recap with a preview of active year ahead213Immix has shared a 12-month recap, capturing key clinical and regulatory events from 2023, setting the stage for an active 2024. Its lead CAR-T asset (NXC-201) is a B-cell maturation antigen (BCMA)...
► Artikel lesen
26.02.Sylvania Platinum - Sluggish PGM prices affect forecasts273Sylvania's Q224 and H124 results were overshadowed by a lower PGM basket price, which resulted in a 10% reduction in revenue. With the delay in the PGM price recovery we expected, we have pared back...
► Artikel lesen
26.02.SATS ASA - Lean and healthy221SATS continues manifestly to deliver on its strategy of premiumisation with currency adjusted membership revenue up 11% in Q423 (15% for the full year) and assurance of 'significant unleashed potential'...
► Artikel lesen